Arcus Biosciences, Inc. (RCUS) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$96.00M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$134.00M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$142.00M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$8.00M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2017-03-31 to 2018-09-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$96.00M | (m) | $33.00M | (m) | $0.00* | -$119.00M* | (m) | $113.00M | (m) | $0.00 |
|---|
| 2026-03-31 | Reported | (m) | -$134.00M | (m) | $7.00M | (m) | $0.00 | -$138.00M | (m) | $122.00M | (m) | $0.00 |
|---|
| 2025-09-30 | Reported | (m) | -$142.00M | (m) | $6.00M | (m) | $0.00* | -$97.00M* | (m) | $141.00M | (m) | $0.00 |
|---|
| 2025-06-30 | Reported | (m) | -$8.00M | (m) | $8.00M | (m) | $0.00* | -$133.00M* | (m) | $139.00M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | (m) | -$122.00M | (m) | $8.00M | (m) | $1.00M | -$132.00M | (m) | $122.00M | (m) | $0.00 |
|---|
| 2024-09-30 | Reported | (m) | -$105.00M | (m) | $7.00M | (m) | $1.00M* | $26.00M* | (m) | $123.00M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | -$106.00M | (m) | $11.00M | (m) | $0.00* | -$94.00M* | (m) | $115.00M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | (m) | -$16.00M | (m) | $10.00M | (m) | $4.00M | -$2.00M | (m) | $109.00M | (m) | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$80.00M | (m) | $32.00M | (m) | $10.00M* | -$63.00M* | (m) | $82.00M | (m) | $2.00M |
|---|
| 2023-06-30 | Reported | (m) | -$83.00M | (m) | $29.00M | (m) | $5.00M* | -$57.00M* | (m) | $84.00M | (m) | $1.00M |
|---|
| 2023-03-31 | Reported | (m) | -$86.00M | (m) | $25.00M | (m) | $3.00M | -$98.00M | (m) | $81.00M | (m) | $2.00M |
|---|
| 2022-09-30 | Reported | (m) | -$70.00M | (m) | $33.00M | (m) | $2.00M* | -$81.00M* | (m) | $77.00M | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | (m) | -$69.00M | (m) | $27.00M | (m) | $1.00M* | -$65.00M* | (m) | $70.00M | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | (m) | -$67.00M | (m) | $18.00M | (m) | $3.00M | $654.00M | (m) | $61.00M | (m) | $1.00M |
|---|
| 2021-09-30 | Reported | (m) | -$78.14M | (m) | $9.46M | (m) | $7.86M* | -$53.76M* | (m) | $71.25M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$76.14M | (m) | $9.46M | (m) | $6.07M* | -$74.00M* | (m) | $68.77M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | (m) | -$72.75M | (m) | $9.46M | (m) | $3.64M | -$66.32M | (m) | $66.39M | (m) | $0.00 |
|---|
| 2020-09-30 | Reported | (m) | $1.55M | (m) | $64.53M | (m) | $1.07M* | $216.26M* | (m) | $51.80M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$45.38M | (m) | $1.75M | (m) | $256.00K* | -$23.94M* | (m) | $35.69M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$28.40M | (m) | $1.75M | (m) | $209.00K | -$31.28M | (m) | $23.14M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$23.25M | (m) | $1.75M | (m) | $550.00K* | -$27.40M* | (m) | $17.24M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$29.16M | (m) | $1.75M | (m) | $551.00K* | -$19.75M* | (m) | $25.00M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$18.77M | (m) | $1.75M | (m) | $628.00K | -$16.84M | (m) | $15.55M | (m) | (m) |
|---|
| 2018-09-30 | Reported | -$11.25M | (m) | (m) | (m) | -262.06% | $1.13M* | -$11.77M* | (m) | $12.86M | (m) | (m) |
|---|
| 2018-06-30 | Reported | -$15M | (m) | (m) | (m) | -1199.92% | $1.30M* | -$10.88M* | (m) | $13.70M | (m) | (m) |
|---|
| 2018-03-31 | Reported | -$12.53M | (m) | (m) | (m) | -1002.48% | $1.05M | -$13.25M | (m) | $11.65M | (m) | (m) |
|---|
| 2017-09-30 | Reported | -$22.43M | (m) | (m) | (m) | -13763.19% | $839.00K* | -$24.23M* | (m) | $21.43M | (m) | (m) |
|---|
| 2017-06-30 | Reported | -$9.06M | (m) | (m) | (m) | (m) | $2.24M* | -$6.82M* | (m) | $7.83M | (m) | (m) |
|---|
| 2017-03-31 | Reported | -$6.8M | (m) | (m) | (m) | (m) | $2.14M | -$9.60M | (m) | $5.80M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$386.00M | (m) | $33.00M | (m) | $2.00M | -$482.00M | (m) | $523.00M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$330.00M | (m) | $51.00M | (m) | $6.00M | -$170.00M | (m) | $448.00M | (m) | $1.00M |
|---|
| 2023-12-31 | Reported | (m) | -$340.00M | (m) | $37.00M | (m) | $24.00M | -$306.00M | (m) | $340.00M | (m) | $6.00M |
|---|
| 2022-12-31 | Reported | (m) | -$280.00M | (m) | $38.00M | (m) | $6.00M | $438.00M | (m) | $288.00M | (m) | $1.00M |
|---|
| 2021-12-31 | Reported | (m) | $54.00M | (m) | $383.00M | (m) | $26.00M | -$256.00M | (m) | $257.00M | (m) | $2.00M |
|---|
| 2020-12-31 | Reported | (m) | -$124.00M | (m) | $78.00M | (m) | $3.00M | $111.00M | (m) | $159.00M | (m) | (m) |
|---|
| 2019-12-31 | Reported | (m) | -$88.71M | (m) | $15.00M | (m) | $1.93M | -$73.46M | (m) | $78.48M | (m) | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$54.86M | (m) | $8.35M | (m) | $3.74M | -$43.00M | (m) | $49.65M | (m) | (m) |
|---|
| 2017-12-31 | Reported | (m) | -$53.44M | (m) | (m) | (m) | $5.51M | -$25.06M | (m) | $47.22M | (m) | (m) |
|---|
| 2016-12-31 | Reported | (m) | -$18.18M | (m) | (m) | (m) | $4.10M | -$12.94M | (m) | $14.25M | (m) | (m) |
|---|